Logos Global Management LP - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 70 filers reported holding DICE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Logos Global Management LP ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$11,746,500
-43.0%
410,000
-37.9%
1.68%
-30.3%
Q4 2022$20,592,000
-6.4%
660,000
-39.2%
2.41%
-10.9%
Q3 2022$22,009,000
+43.9%
1,085,251
+10.1%
2.71%
-3.5%
Q2 2022$15,291,000
-42.3%
985,251
-28.9%
2.80%
-18.4%
Q1 2022$26,500,000
-37.1%
1,385,251
-16.8%
3.44%
-20.9%
Q4 2021$42,122,000
+10.9%
1,664,251
+43.4%
4.34%
+58.5%
Q3 2021$37,998,0001,160,2512.74%
Other shareholders
DICE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$62,993,00033.95%
Sands Capital Ventures, LLC 3,148,970$60,240,00012.58%
OUP Management Co., LLC 536,693$10,267,0007.82%
New Leaf Venture Partners, L.L.C. 556,693$10,650,0005.25%
Logos Global Management LP 1,385,251$26,500,0003.44%
Soleus Capital Management, L.P. 983,994$18,824,0002.43%
RA Capital Management 5,208,911$99,646,0002.17%
Deep Track Capital, LP 1,250,000$23,913,0001.53%
Samsara BioCapital, LLC 228,466$4,371,0001.10%
HighVista Strategies LLC 48,960$937,0000.60%
View complete list of DICE THERAPEUTICS INC shareholders